Preparation method of ADH (alcohol dehydrogenase) and GDH (glucose dehydrogenase) co-crosslinked enzyme aggregates

A technology of glucose dehydrogenase and alcohol dehydrogenase, applied in biochemical equipment and methods, enzymes, multi-enzyme systems, etc., can solve problems such as difficult chiral compounds and complex synthesis processes

Active Publication Date: 2018-05-04
SHANGHAI INST OF PHARMA IND +1
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

(S)-1-(2,6-dichloro-3-fluorophenyl)ethanol is mostly synthesized by chemical methods, but it is not easy to obtain h

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of ADH (alcohol dehydrogenase) and GDH (glucose dehydrogenase) co-crosslinked enzyme aggregates
  • Preparation method of ADH (alcohol dehydrogenase) and GDH (glucose dehydrogenase) co-crosslinked enzyme aggregates
  • Preparation method of ADH (alcohol dehydrogenase) and GDH (glucose dehydrogenase) co-crosslinked enzyme aggregates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Co-expression of alcohol dehydrogenase and glucose dehydrogenase

[0063] Use specific restriction endonucleases NdeI and XhoI (Thermo, USA) to double-enzyme digest the plasmid containing ADH and GDH. After electrophoresis, the target fragments are gel-cut and recovered. Carrier plasmid pET-28a is also double-digested with NdeI and XhoI. Enzyme digestion and gel recovery. The ADH and GDH gene fragments were respectively connected with the carrier fragments to obtain plasmids pET-28a-adh and pET-28a-gdh, both of which were resistant to ampicillin and kanamycin. The two plasmids were transformed into competent cells E.coliDH5α to obtain the co-expression strain E.coli BL21-ADH / GDH of alcohol dehydrogenase and glucose dehydrogenase. The co-expression strain was inoculated into LB medium containing ampicillin (Amp, 100 μg / ml) and kanamycin (Kan, 100 μg / ml), and cultivated overnight at 37° C. with a constant temperature shaker at 230 r / min. According to the volume ratio of...

Embodiment 2

[0066] Precipitant selection

[0067] The specific implementation steps are as follows:

[0068] (1) In this paper, 1000 μl, 900 μl, 800 μl, 700 μl, 600 μl, and 500 μl of ethanol, acetone, and saturated ammonium sulfate solution were respectively mixed with 0 μl, 100 μl, 200 μl, 300 μl, 400 μl, and 500 μl of 0.1mol / L pH7.0 The TEA buffer solutions were mixed to prepare precipitants with volume concentrations of 100%, 90%, 80%, 70%, 60%, and 50%.

[0069] (2) Take 1ml of precipitants of different concentrations in 1.5ml EP tubes, put them in an ice-water bath for pre-cooling for 5 minutes, add 200 μl of crude enzyme solution, shake in an ice-water bath at 150r / min for 30 minutes, and then centrifuge. The above liquid is used to determine the protein content.

[0070] (3) The pellet was resuspended with 600 μl TEA buffer solution for the determination of enzyme activity. The result is as figure 2 As shown, when 90% acetone was used to precipitate the crude enzyme solution, t...

Embodiment 3

[0072] Preparation of co-crosslinked enzyme aggregates

[0073] The specific implementation steps are as follows:

[0074] (1) Take 18ml of acetone and 2ml of TEA buffer solution to prepare a 90% acetone solution in a beaker, seal it and put it in an ice-water bath, start stirring after precooling for 5 minutes, slowly add 4ml of crude enzyme solution dropwise, stir and precipitate for 30 minutes.

[0075] (2) 480 μl of glutaraldehyde solution with a volume fraction of 2.5% was added dropwise. At this time, the mass ratio of glutaraldehyde:total protein in the solution was 0.5, and stirred on an ice-water bath for 1.5 hours.

[0076] (3) Take 2ml of the cross-linked immobilized enzyme and centrifuge at 3000r / min, 4°C for 2min to remove the supernatant, wash it three times with an equal volume of TEA buffer solution, and resuspend the cross-linked enzyme aggregate with 1ml of TEA buffer solution for enzyme Viability assay.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of ADH (alcohol dehydrogenase) and GDH (glucose dehydrogenase) co-crosslinked enzyme aggregates. Specifically, a supernatant obtained after high-density fermentation and wall-breaking centrifugation is taken as a crude enzyme liquid, ADH and GDH in the crude enzyme liquid are subjected to glutaraldehyde cross-linking for preparation of the co-crosslinkedenzyme aggregates, and enzyme activity recovery of the co-crosslinked enzyme aggregates is increased to 82% by adding Tween 80.

Description

technical field [0001] The invention relates to the preparation of a co-crosslinked enzyme aggregate of alcohol dehydrogenase and glucose dehydrogenase and the research on the stability and reuse rate of the enzyme aggregate, belonging to the technical field of enzyme immobilization. Background technique [0002] On August 3, 2011, the US Food and Drug Administration approved crizotinib produced by Pfizer for the treatment of NSCLC with ALK gene rearrangement. On March 11, 2016, it was approved for the treatment of NSCLC with ROS1 gene mutation, and its market demand continues to increase. During its synthesis, (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol is the key chiral intermediate. (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol is mostly synthesized by chemical methods, but it is not easy to obtain high-purity chiral compounds, and the synthesis process is complicated. Biosynthesis can overcome these disadvantages . [0003] The latest existing biosynthesis technology is t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N11/18C12P5/00
CPCC12N9/0006C12N11/18C12P5/005C12Y101/01001C12Y101/9901
Inventor 邵雷陈代杰胡晓植郑昆张骏梁
Owner SHANGHAI INST OF PHARMA IND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products